Myers Stephen P., Vigar Vanessa
Phytomedicine, 2017
Abstract
Objective
To critically assess the evidence for a specific standardised extract of Trifolium pratense isoflavones (Promensil) at a dosage of 80mg/day in the treatment of menopausal hot flushes.
Data sources
Systematic literature searches were performed in Medline, Scopus, CINAHL Plus, Cochrane, AMED and InforRMIT and citations obtained from 1996 to March 2016. Reference lists were checked; corresponding authors contacted and the grey literature searched for additional publications. REVIEW
Methods
Studies were selected according to predefined inclusion and exclusion criteria. All randomised clinical trials of a specific standardised extract of Trifolium pratense isoflavones (Promensil) used as a mono-component at 80mg/day and measuring vasomotor symptoms were included. The data extraction and quality assessment were performed independently by one reviewer and validated by a second with any disagreements being settled by discussion. Weighted mean differences and 95% confidence intervals were calculated for continuous data using the fixed-effects model.
Results
Twenty potentially relevant papers were identified, with only five studies meeting the inclusion criteria. The meta-analysis demonstrated a statistical and clinically relevant reduction in hot flush frequency in the active treatment group compared to placebo. Weighted mean difference 3.63 hot flushes per day: [95% CI 2.70-4.56]; p˂0.00001). Due to a lack of homogeneity a priori defined sub-group analyses were performed demonstrating a substantive difference between cross-over and parallel-arm clinical trial designs.
Conclusion
There is evidence for a statistical and clinically significant benefit for using a specific standardised extract of red clover isoflavones (Promensil) at 80mg/day for treating hot flushes in menopausal women across the 3 studies included in the meta-analysis. The preparation was safe over the short-term duration of the studies (3 months).
Copyright © 2016 The Authors. Published by Elsevier GmbH.. All rights reserved.
Keywords
Hot flushes; Isoflavones; Menopause; Red clover; Standardisation; Trifolium pratense
| PMID: | 28160855 |
|---|---|
| Category: | Menopause |
The best supplements with Trifolium Pratense in Menopause category:
- Menopause Support, 90 Veg Capsules (Now Foods) - NOW Menopause Support has recommended potencies of key ingredients that have been shown to support healthy response to the natural changes occurring during menopause. It contains among others: Trifolium Pratense.
Articles similar to "Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis."
- The role of Trifolium Pratense in Menopause: Evaluation of estrogenic activity of red clover (Trifolium pratense L.) sprouts cultivated under different conditions by content of isoflavones, calorimetric study and molecular modelling. (Isoflavones have an affinity for estrogen receptors (ERs) including beneficial affinity for ERβ...)
- The impact of Trifolium Pratense on Menopause: Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms. ( Natural estrogen decline leads to vasomotor symptoms (VMS)... Results suggest that moderate doses of RCE were more effective and superior to placebo in reducing physiological and self-reported VMS. Findings support that objective physiological symptom assessment methods should be used together with self-report measures in future studies on menopausal VMS. TRIAL REGISTRATION: ClinicalTrials.gov NCT02028702.)
- The significance of Trifolium Pratense for Menopause: Effects of red clover on perimenopausal and postmenopausal women's blood lipid profile: A meta-analysis. (The study aimed to perform a systematic review with meta-analysis of randomized controlled trials (RCTs) to access the effects of red clover isoflavones on the blood lipid profile of both perimenopausal and postmenopausal women... Results suggest that moderate doses of RCE were more effective and superior to placebo in reducing physiological and self-reported VMS. Findings support that objective physiological symptom assessment methods should be used together with self-report measures in future studies on menopausal VMS. TRIAL REGISTRATION: ClinicalTrials.gov NCT02028702.)
- The role of Trifolium Pratense in Menopause: Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial. (OBJECTIVES: Menopausal women are interested in alternative therapy to alleviate climacteric symptoms... These results indicated that, compared to placebo, dried leaves of red clover were more effective in reducing the severity of menopausal symptoms in postmenopausal women. )
- The impact of Trifolium Pratense on Menopause: Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation. ( Red clover is an important source of isoflavones; which has been made commercially available as dietary supplements for the treatment of menopausal symptoms... This study is the first to provide detailed data on RCI bioavailability in humans and determine no influence of FOS yet a trend toward increased equol production. More research is warranted involving a greater sample size. )
- The significance of Trifolium Pratense for Menopause: Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. (OBJECTIVE: To perform a meta-analysis examining the efficacy of phytoestrogens for the relief of menopausal symptoms... Phytoestrogens appear to reduce the frequency of hot flushes in menopausal women, without serious side-effects. )
- The role of Trifolium Pratense in Menopause: Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis. (OBJECTIVE: To critically evaluate the effect of red clover on hot flash, endometrial thickness, and hormones status in postmenopausal and peri- and post-menopausal women... Red clover had a positive effect of alleviating hot flash in menopausal women. Our data, however, suggested very slight changes in FSH, LH, testosterone, and SHBG and significant effect in estrogen status by red clover consumption. However, the interpretation of results of the current study is limited due to methodological flaws of the included studies, menopause status, and large heterogeneity among them. Further trials are still needed to confirm the current finding. )
Previous article
Elemental analysis and nutritional value of edible Trifolium (clover) species.
Next article
Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women.